CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Growth in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totaling 100,000 shares, a growth of 151.6% from the June 15th total of 39,741 shares. Based on an average daily trading volume, of 7,124,353 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Stock Performance

Shares of OTCMKTS:CBDL opened at $0.00 on Thursday. CBD Life Sciences has a 52-week low of $0.00 and a 52-week high of $0.00.

CBD Life Sciences Company Profile

CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.